Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells

Journal of General Virology

Volumn 86, Issue 9, 2005, Pages 2421-2432

  Pierce, Amy T ^a   DeSalvo, Joanna ^a   Foster, Timothy P ^b   Kosinski, Athena ^c   Weller, Sandra K ^c   Halford, William P ^d  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; VIRUS DNA;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG POTENTIATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; VERO CELL; VIRION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; DNA, VIRAL; DRUG SYNERGISM; HERPESVIRUS 1, HUMAN; INTERFERON TYPE II; INTERFERON-BETA; RECEPTORS, INTERFERON; VERO CELLS; VIRION; VIRUS REPLICATION;

ANIMALIA; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 23844487583     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80979-0     Document Type: Article

References (34)

1. Balish, M. J., Abrams, M. E., Pumfery, A. M. & Brandt C. R. (1992). Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-α and -γ. J Infect Dis 166, 1401-1403.
2. 134.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-α. Virology 307, 290-300.
3. Chen, S. H., Oakes, J. E. & Lausch, R. N. (1994). Synergistic antiherpes effect of TNF-α and IFN-γ in human corneal epithelial cells compared with that in corneal fibroblasts. Antiviral Res 25, 201-213.
4. DeLuca, N. A. & Schaffer, P. A. (1987). Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res 15, 4491-4511.
5. DeLuca, N. A., McCarthy, A. M. & Schaffer, P. A. (1985). Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 56, 558-570.
6. Desloges, N., Rahaus, M. & Wolff, M. H. (2005). Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon. J Gen Virol 86, 1-6.
7. Ellon, G. B. (1983). The biochemistry and mechanism of action of acyclovir. J Antimicrob Chemother 12 (Suppl. B), 9-17.
8. Foster, T. P., Rybachuk G. V., Alvarez, X., Borkhsenious, O. & Kousoulas, K. G. (2003). Overexpression of gK in gK-transformed cells collapses the Golgi apparatus into the endoplasmic reticulum inhibiting virion egress, glycoprotein transport, and virus-induced cell fusion. Virology 317, 237-252.
9. Foster, T. P., Melancon, J. M., Baines, J. D. & Kousoulas, K. G. (2004). The herpes simplex virus type 1 UL20 protein modulates membrane fusion events during cytoplasmic virion morphogenesis and virus-induced cell fusion. J Virol 78, 5347-5357.
10. Hafford, W. P., Halford, K. J. & Pierce, A. T. (2005a). Mathematical analysis demonstrates that interferons-β and -γ interact in a multiplicative manner to disrupt herpes simplex virus replication. J Theor Biol 234, 439-454.
11. Halford, W. P., Maender, J. L. & Gebhardt, B. M. (2005b). Reevaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1. Virol J (in press).
12. Härle, P., Sainz, B., Jr, Carr, D. J. J. & Halford, W. P. (2002). The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-α/β. Virology 293, 295-304.
13. Hubenthal-Voss, J., Houghten, R. A., Pereira, L. & Rolzman, B. (1988). Mapping of functional and antigenic domains of the α4 protein of herpes simplex virus 1. J Virol 62, 454-462.
14. + T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18, 593-603.
15. Leib, D. A., Machalek, M. A., Williams, B. R. G., Silverman, R. H. & Virgin, H. W. (2000). Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A 97, 6097-6101.
16. Luker, G. D., Prior, J. L., Song, J., Pica, C. M. & Leib, D. A. (2003). Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol 77, 11082-11093.
17. Malik, A. K., Martinez, R., Muncy, L., Carmichael, E. P. & Weller, S. K. (1992). Genetic analysis of the herpes simplex virus type 1 UL9 gene: isolation of a lacZ insertion mutant and expression in eukaryotic cells. Virology 190, 702-715.
18. Mossman, K. L. & Smiley, J. R. (2002). Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J Virol 76, 1995-1998.
19. Mossman, K. L., Saffran, H. A. & Smiley, J. R. (2000). Herpes simplex virus ICPO mutants are hypersensitive to interferon. J Virol 74, 2052-2056.
20. Park, S.-Y., Seol, J.-W., Lee, Y.-J. & 9 other authors (2004). IFN-γ enhances TRAIL-induced apoptosis through IRF-1. Eur J Biochem 271, 4222-4228.
21. Poon, A. P. W., Silverstein, S. J. & Roizman, B. (2002). An early regulatory function required in a cell type-dependent manner is expressed by the genomic but not the cDNA copy of the herpes simplex virus 1 gene encoding infected cell protein 0. J Virol 76, 9744-9755.
22. Sainz, B., Jr & Halford, W. P. (2002). Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J Virol 76, 11541-11550.
23. Sainz, B., Jr, Mossel, E. C., Peters, C. J. & Garry, R. F. (2004). Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 329, 11-17.
24. Sainz, B., Jr, LaMarca, H. L., Garry, R. F. & Morris, C. A. (2005). Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol J 2, 14.
25. Schang, L. M., Phillips, J. & Schaffer, P. A. (1998). Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol 72, 5626-5637.
26. Simmons, A. & Tscharke, D. C. (1992). Anfi-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J Exp Med 175, 1337-1344.
27. Smith, K. O. (1964). Relationship between the envelope and the infectivity of herpes simplex virus. Proc Soc Exp Biol Med 115, 814-816.
28. Soboleski, M. R., Oaks, J. & Halford, W. P. (2005). Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells. FASEB J 19, 440-442.
29. Takaoka, A., Hayakawa, S., Yanai, H. & 8 other authors (2003). Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516-523.
30. Tallarida, R. J. (2001). Drug synergism: its detection and applications. J Pharmacol Exp Ther 298, 865-872.
31. Tallarida, R. J., Stone, D. J., Jr & Raffa, R. B. (1997). Efficient designs for studying synergistic drug combinations. Life Sci 61, PL417-PL425.
32. Theil, D., Derfuss, T., Paripovic, I., Herberger, S., Meinl, E., Schueler, O., Strupp, M., Arbusow, V. & Brandt, T. (2003). Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 163, 2179-2184.
33. Vollstedt, S., Arnold, S., Schwerdel, C., Franchini, M., Alber, G., Di Santo, J. P., Ackermann, M. & Suter, M. (2004). Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol 78, 3846-3850.
34. Warner, M. S., Geraghty, R. J., Martinez, W. M., Montgomery, R. I., Whitbeck, J. C., Xu, R., Eisenberg, R. J., Cohen, G. H. & Spear, P. G. (1998). A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246, 179-189.